Novartis Pharmaceuticals: See what lies beneath

Novartis, a healthcare company, raised awareness of the PIK3CA genetic mutation in Hong Kong via an interactive art exhibition.

Summary

Breast cancer patients with the PIK3CA genetic mutation respond poorer to traditional treatment and have a worse survival rate. Alarmingly, most women don't know this.

A genetic test can potentially change their disease outcome. However, tests for the PIK3CA mutation are not publicly funded in Hong Kong, which means it is an 'extra step' that patients may miss during their treatment journey. Novartis wanted to empo

WARC subscribers can sign in to keep reading

Not a subscriber?

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

WARC consistently delivers valuable insights that help to make me look like an expert in front of my colleagues and clients.

Dasha Boryso
Strategy Partner, Fetch

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands